Medical device licence · 7702 · Class 2
ABBOTT VISION SYSTEM
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed July 12, 1999; ended November 26, 2003. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 7702
- Licence holder
- Abbott Laboratories Diagnostics DivisionAbbott Park, IL, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- July 12, 1999
- Ended
- November 26, 2003
- Devices covered
- 27
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- TRIGLYCERIDES VISION
- VISION ALBUMIN
- VISION ALKALINE PHOSPHATASE
- VISION AMYLASE
- VISION ANALYZER
- VISION CALCIUM
- VISION CHEMICAL CALIBRATORS
- VISION CHEMICAL CONTROLS
- VISION CHOLESTEROL
- VISION CREATINE KINASE
- VISION CREATININE
- VISION CRP REAGENT
- VISION GLUCOSE
- VISION GLYCATED HB (HEMOGLOBIN)
- VISION GLYCATED HB CALIBRATORS
- VISION GLYCATED HB CONTROLS
- VISION HDL CHOLESTEROL
- VISION HEMOGLOBIN
- VISION LDH REAGENT
- VISION SGOT (AST)
- VISION SGPT(ALT)
- VISION THYROXINE (T4)
- VISION TOTAL BILILUBIN
- VISION TOTAL PROTEIN
- VISION UREA NITROGEN
- VISION URIC ACID
- VISION WHOLE BLOOD HDL CHOLESTEROL
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.